Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 15;7:10. doi: 10.1038/s41525-022-00281-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 3 — Distribution of the predicted weekly dose (mg) of warfarin in the Qatari population (yellow) using the IWPC algorithm based on age, sex, height, weight, ethnicity, the concurrent use of drugs that decrease warfarin requirements, and the genotypes/diplotypes of VKORC1 and CYP2C9. Also shown is the distribution of dosage in patients of European ethnicity from the EU-PACT trial (blue). Weekly doses in mg are plotted in the Y-axis for the two populations. The box is drawn with the interquartile range and the central horizontal line showing the median, while values above the range shown as whiskers. Individuals with values ≤21 mg per week (below the bottom horizontal line) would be predicted to need a lower dose, and those with values ≥49 mg per week (above the top horizontal line) would be predicted to need a higher dose.